advertisement
Lane S 9
Showing records 1 to 9 | Display all abstracts from Lane S82148 Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study
Reiss G
American Journal of Ophthalmology 2019; 208: 219-225
82145 Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent
Lass JH; Benetz BA
American Journal of Ophthalmology 2019; 208: 211-218
82148 Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study
Clifford B; Vold S
American Journal of Ophthalmology 2019; 208: 219-225
82145 Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent
He J; Hamilton C; Hamilton C
American Journal of Ophthalmology 2019; 208: 211-218
82148 Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study
He J; Hamilton C; Hamilton C
American Journal of Ophthalmology 2019; 208: 219-225
82145 Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent
Von Tress M; Dickerson J
American Journal of Ophthalmology 2019; 208: 211-218
82148 Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study
Dickerson J
American Journal of Ophthalmology 2019; 208: 219-225
82145 Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent
Lane S
American Journal of Ophthalmology 2019; 208: 211-218
82148 Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study
Lane S
American Journal of Ophthalmology 2019; 208: 219-225
